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Abstract. 
 
The mitotic apparatus plays a pivotal role in 
dividing cells to ensure each daughter cell receives a 
full set of chromosomes and complement of cytoplasm 
during mitosis. A human homologue of the 
 
Drosophila
 
 
warts tumor suppressor, h-warts/LATS1, is an evolu-
tionarily conserved serine/threonine kinase and a dy-
namic component of the mitotic apparatus. We have 
identiﬁed an interaction of h-warts/LATS1 with zyxin, a 
regulator of actin ﬁlament assembly. Zyxin is a compo-
nent of focal adhesion, however, during mitosis a frac-
tion of cytoplasmic-dispersed zyxin becomes associated 
with h-warts/LATS1 on the mitotic apparatus. We 
found that zyxin is phosphorylated speciﬁcally during 
mitosis, most likely by Cdc2 kinase, and that the phos-
phorylation regulates association with h-warts/LATS1. 
Furthermore, microinjection of truncated h-warts/
LATS1 protein, including the zyxin-binding portion, in-
terfered with localization of zyxin to mitotic apparatus, 
and the duration of mitosis of these injected cells was 
signiﬁcantly longer than that of control cells. These 
ﬁndings suggest that h-warts/LATS1 and zyxin play a 
crucial role in controlling mitosis progression by form-
ing a regulatory complex on mitotic apparatus.
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phosphorylation • serine/threonine kinase
 
Introduction
 
Mitotic apparatus, which consists of a dynamic array of mi-
crotubules and associated proteins, controls mitotic events
such as establishment of cell polarity, chromosomal con-
gression and segregation, and finally, cytokinesis. Genetic
analyses in yeasts and 
 
Drosophila
 
 have identified several
kinases essential for normal regulation of mitosis (Glover
et al., 1995; Sunkel and Glover, 1988). These mitosis-
related serine/threonine kinases have been found to be
highly conserved evolutionarily and localized to the mi-
totic apparatus (Golsteyn et al., 1995; Kimura et al., 1997).
Dynamic interaction of these mitosis-related kinases with
proteins on the mitotic apparatus is considered to be re-
quired to achieve proper coordination of mitotic events
(Bahler et al., 1998; Nigg, 1998; Bischoff and Plowman,
1999).
The 
 
warts
 
 gene (also known as 
 
lats
 
) was identified as a
tumor suppressor of 
 
Drosophila melanogaster 
 
(Justice et al.,
1995; Xu et al., 1995). The 
 
warts/lats
 
 encodes serine/threo-
nine kinase sharing a high identity with the catalytic do-
main of myotonic dystrophy protein kinase (DMPK)
 
1
 
 fam-
ily, many of which are known to be involved in various
mitotic events. Among the DMPK family proteins, 
 
Sac-
charomyces cerevisiae
 
 Dbf2 was found to be required for
completion of mitosis; mutation in 
 
Dbf2
 
 results in a dumb-
bell-shape phenotype, which is the consequence of cell di-
vision failure (Toyn and Johnston, 1994). Orb6, a DMPK
homologue in 
 
Schizosaccharomyces pombe
 
, plays a role in
coordinating cell morphogenesis with the cell cycle. Orb6
is known to possess dual functions of both organizing the
actin cytoskeleton and negative regulation of mitosis by
affecting cdc2 (Verde et al., 1998). The human Rho-associ-
ated kinase (Rho kinase) and citron-K kinase, DMPK
family members, have been shown to be involved in the
regulation of cytokinesis (Madaule et al., 1998; Yasui et al.,
1998).
 
A human homologue of the 
 
warts/lats
 
 gene, termed
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h-warts/LATS1
 
, has been identified and demonstrated to
negatively regulate Cdc2 activity by interacting with Cdc2
in the mitotic phase (Tao et al., 1999). Analogous to its
mutant in 
 
Drosophila
 
, mice deficient of 
 
LATS1
 
 gene have
been shown to develop malignant tumors (St. John et al.,
1999). Moreover, h-warts/LATS1 protein was found to lo-
calize at the centrosome in interphase and to translocate
dynamically toward mitotic spindles in metaphase-ana-
phase, and, finally, to the midbody by telophase (Nish-
iyama et al., 1999). Recently, the Sid2 kinase, structural
homologue of Dbf2 and a potential counterpart of h-warts/
LATS1 in fission yeast, has been demonstrated to function
as part of a novel signaling pathway required for onset of
cytokinesis. Sid2 is a component of the spindle pole body
and by virtue of its transient localization to the division
site, it appears to determine the timing of ring constriction
(Sparks et al., 1999). Based on these observations, h-warts/
LATS1 is speculated to be heavily involved in mitotic
events in mammalian cells and that loss of its function dis-
rupts normal cell cycle regulation, leading to the develop-
ment of tumors. Therefore, identification of cellular tar-
gets of the h-warts/LATS1 protein will provide clues to its
precise cell cycle function and to its involvement in tumor-
igenesis.
During mitosis, adherent cells change morphology into a
spheroid and weakly adherent form. This morphological
alteration involves rearrangement of cytoskeletal systems
and dissociation of the adhesion apparatus, which are un-
der the control of biochemical status through cell cycle
progression (Verde et al., 1998). Focal adhesion plaques
are an adhesion apparatus for cells to contact the extracel-
lular matrix where the growing end of actin filament at-
taches to the plasma membrane. At the focal adhesion
complex, a number of proteins serve as linkages between
transmembrane proteins and the actin cytoskeleton, regu-
lating actin filament dynamics (Craig and Johnson, 1996;
Beckerle, 1997). As cells proceed through mitosis, compo-
nents of the focal adhesion complex are known to dissoci-
ate into the cytoplasm when bundles of actin fibers disap-
pear. The role of these actin-regulatory proteins during
mitosis, which are dispersed in the cytoplasm, remains to
be established.
Zyxin is a component of the focal adhesion complex
(Crawford and Beckerle, 1991) and plays a central role in
actin filament polymerization in mammalian cells (re-
viewed in Beckerle, 1997). Several lines of evidence dem-
onstrate that zyxin may function to recruit components re-
quired for the actin assembly machinery to specific sites in
the cell and to stimulate spatially restricted actin polymer-
ization (Crawford et al., 1992; Reinhard et al., 1995; Hobert
et al., 1996; Prehoda et al., 1999). Interestingly, zyxin ex-
hibits a functional nuclear export signal and has been dem-
onstrated to shuttle between the nucleus and the sites of
cell adhesion (Nix and Beckerle, 1997). These findings
suggest that zyxin has an unknown second function in ad-
dition to its key role in regulating actin assembly.
In this study, we have identified the interaction of
h-warts/LATS1 with zyxin on the mitotic apparatus during
mitosis. The localization of zyxin on the mitotic apparatus
appears to be dependent on the presence of h-warts/
LATS1 protein. Furthermore, we showed that zyxin is
phosphorylated specifically during mitosis, most likely by
 
Cdc2 kinase, and that this phosphorylation controls the as-
sociation of zyxin with h-warts/LATS1. The interaction
between zyxin and h-warts/LATS1 on the mitotic appara-
tus implicates a significant role for actin regulatory pro-
teins during mitosis.
 
Materials and Methods
 
Yeast Two-Hybrid Screening
 
Yeast strain L40 was used as a host for the two-hybrid screening (Vojtek
et al., 1993). An L40 strain carrying pBTM116HA/h-warts (amino acids
394–675) was transformed with the HeLa cDNA library constructed in
pGAD-GH (Clontech) by electroporation. Transformants were screened
for growth on SD plate media lacking tryptophan, leucine, and histidine
prototrophy. His
 
1
 
 colonies were subjected to 
 
b
 
-galactosidase assay. Plas-
mids harboring cDNA were recovered from positive colonies and the nu-
cleotide sequence of plasmid DNA which conferred the LacZ
 
1
 
 phenotype
on L40 containing pBTM116HA/h-warts (396–657) were determined.
 
Cell Culture, Synchronization, and Transfections
 
HeLa, COS7, and U2OS cells were cultured in DME/F12 supplemented
with 10% fetal calf serum without antibiotics. HeLa cells were synchro-
nized at the beginning of S phase by double thymidine block and release
protocol (first 24 h incubation with 1 mM thymidine, an interval of thymi-
dine-free incubation for 8 h, and second thymidine incubation for 14 h).
Mitotic cells were collected by mechanical shake-off from the culture
plate 9.5 h after release from S phase. For transient transfection, cells in
6-well plates were transfected using FuGene6 transfection reagent follow-
ing the manufacturer’s instructions (Boehringer Mannheim). To prepare
for flow cytometry, cells were trypsinized, fixed with 70% methanol, and
DNA were stained with propidium iodide. Cells were subjected to flow
cytometry on FACScan
 
®
 
 (Becton Dickinson). G1, S, and G2/M popula-
tions were calculated with ModFit 2.1 software (Varity).
 
Expression Plasmids
 
Mammalian expression plasmids were constructed by subcloning the PCR
amplified fragment into hemagglutinin 1 (HA)-tagged (pCGN), FLAG-
tagged (pBJ-FLAG) vectors. pBJ-FLAG, was constructed by inserting an
annealed oligonucleotide between the XhoI and BamHI sites of pBJ-myc.
All the PCR products were obtained using PyroBest DNA polymerase
(Takara) and we confirmed their sequences. For glutathione-
 
S
 
-transferase
(GST) fusion protein expression in bacteria, pGEX2TH-based plasmids
were constructed as previously described (Masuko et al., 1999).
 
Antibody Preparation
 
Two polyclonal antibodies against h-warts/LATS1 were generated by in-
jecting rabbits with two synthetic peptides, C1 (PVDPDKLWSDD-
NEEENVNDTLNG), and C2 (SDEDDQNTGSEIKNRDLVYV), cou-
pled to keyhole limpet-hemocyanin (KLH) via the added NH
 
2
 
-terminal
cysteine. GST–h-warts amino acids 136–700 and amino acids 136–410
were also used for immunizing rats, generating G3 and G4 antisera, re-
spectively. The polyclonal antibody against zyxin was generated in rabbit
as previously described (Macalma et al., 1996), or purchased from Santa
Cruz. Monoclonal antibodies for HA-epitope (12CA5) and FLAG-
epitope (M5) were obtained from Boehringer Mannheim and Sigma-Ald-
rich, respectively. Monoclonal antibodies for 
 
a
 
-tubulin (clone B512), vin-
culin and cyclin B were purchased from Sigma-Aldrich and Transduction
Laboratories, respectively.
 
Immunoprecipitation
 
Cells were lysed on ice for 30 min with 0.5% NP-40 lysis buffer consisting
of 0.5% NP-40, 25 mM Tris-Cl, pH 7.5, 137 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 5% glycerol, 2 
 
m
 
g/ml aprotinin, 20 mM 
 
b
 
-glycerophosphate, 1 mM
ABSF, 10 
 
m
 
M leupeptin, 1 
 
m
 
M pepstatin, and 1 mM Na
 
3
 
VO
 
4
 
. Lysates
were centrifuged at 14,000 
 
g
 
 for 20 min. Aliquots of supernatant (200 
 
m
 
g,
 
z
 
2.0 mg/ml) were incubated for 1 h at 4
 
8
 
C with specific antibodies, and
another 1 h incubation after adding 30 
 
m
 
l of protein G/A agarose beads
(50% slurry; Calbiochem). After being washed, the bound proteins were
analyzed by immunoblotting. 
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For coimmunoprecipitation of h-warts/LATS1 and zyxin, HeLa cells
were lysed on ice for 30 min with five cell volumes of the 0.1% NP-40 lysis
buffer (0.1% NP-40, 100 mM NaCl, 25 mM Tris-Cl, pH 8.0, 5 mM EGTA,
1 mM MgCl
 
2
 
 and 5% glycerol supplemented with 1 mM DTT, 2 
 
m
 
g/ml apro-
tinin, 20 mM 
 
b
 
-glycerophosphate, 1 mM ABSF, 10 
 
m
 
M leupeptin, 1 
 
m
 
M
pepstatin, 1 mM Na
 
3
 
VO
 
4
 
, 1 mM benzamidine, and 1 
 
m
 
M microcystin), and
centrifuged at 14,000 
 
g
 
 for 20 min. Precleared 400 
 
m
 
g quantities of cell ly-
sate (
 
z
 
4 mg/ml) were mixed with 3 
 
m
 
l of anti-zyxin antibody for 3 h on ice,
then 15 
 
m
 
l of protein A–Sepharose beads (Amersham Pharmacia) were
added and incubated for another 2 h at 4
 
8
 
C. After washing five times with
the 0.1% NP-40 lysis buffer, the lysate was eluted by boiling for 3 min in
62.5 mM Tris-Cl, pH 6.8, containing 2% SDS and 10% glycerol. The elute
was removed, made to 10 mM DTT and 0.1% bromophenol blue, boiled
again and then subjected to immunoblotting. Quantification analysis was
performed by MacBAS v2.5 software.
 
In Vitro Pull-Down Assay and Solution-Binding Assay
 
For pull-down assay, 30 
 
m
 
g of GST fusion protein was immobilized on glu-
tathione-agarose, and equilibrated with 0.5% NP-40 lysis buffer. Aliquots
of cell lysate (200 
 
m
 
g, 
 
z
 
2.0 mg/ml) were incubated with the glutathione-
agarose for 1 h. The bound proteins were analyzed by immunoblotting. In
vitro solution binding assay was performed as described (Jin et al., 1998).
In brief, 10 
 
m
 
g of GST fusion proteins was immobilized on the glu-
tathione-agarose and equilibrated with buffer B (20 mM Hepes-KOH, pH
7.9, 50 mM NaCl, 1 mM MgCl
 
2
 
, 17% glycerol, and 2 mM DTT). The glu-
tathione-agarose were incubated with 1 
 
m
 
g of His-h-warts in 200 
 
m
 
l of
buffer B for 1 h at 4
 
8
 
C. After extensive washing with buffer B, the bound
proteins were analyzed by immunoblotting.
 
In Vitro Kinase Assay
 
Synchronized HeLa cells were washed with ice-cold PBS and lysed on the
plate with RIPA buffer as previously described (Izawa et al., 1996). Ly-
sates were centrifuged at 14,000 
 
g
 
 for 20 min, and the supernatant was
used for the kinase assays. Kinase reaction were conducted at 25
 
8
 
C for 30
min in a final volume of 50 
 
m
 
l containing 20 mM Tris, pH 7.4, 10 mM
MgCl
 
2
 
, 10 
 
m
 
Ci of 
 
g
 
-[
 
32
 
P]ATP (3,000 Ci/mmol; Amersham Pharmacia), 1 
 
m
 
M
microcystin, 8 
 
m
 
g of cell lysates, and 10 
 
m
 
g of GST-zyxin. Each reaction
mixture was then chilled and mixed with 30 
 
m
 
l of glutathione-agarose
beads (50% slurry) and 0.5 ml of ice-cold TNE buffer, followed by rocking
for 30 min at 4
 
8
 
C. The glutathione-agarose beads were washed and boiled
in 30 
 
m
 
l of Laemmli sample buffer to elute GST fusion proteins. The sam-
ples were resolved by 8% SDS-PAGE and visualized by autoradiography.
The result of gel analyses were quantified by MacBAS (Fujifilm).
 
Depletion of Cdc2
 
Aliquots of 150 
 
m
 
l of mitotic cell lysate (1.0 mg/ml) were incubated with
50 
 
m
 
l of p13-suc1 agarose beads (50% slurry; Upstate Biotechnology) at
4
 
8
 
C for 45 min. After centrifugation, 50 
 
m
 
l of fresh p13 suc1-beads was
added to the supernatant and incubated for an additional 30 min. The
Cdc2 kinase assay was performed by the SignaTECT assay system
(Promega) in which biotinylated peptide derived from histone H1 was
used as a substrate and radiolabeled phosphorylated substrate was recov-
ered with streptoavidin matrix. The purified active Cdc2 kinase was pre-
pared as previously described (Kusubata et al., 1992).
 
Immunofluorescence Microscopy
 
U2OS cells were grown on a 35-mm petri dish to 
 
z
 
70% confluence, fixed
with 4% paraformaldehyde/PBS, pH 7.4, for 15 min at room temperature,
followed by permeabilization with 0.2% Triton X-100/PBS, otherwise
fixed with a methanol/acetone solution for 10 min on ice. A preextraction
protocol was performed either with 7.5 
 
m
 
g/ml digitonin in KHM buffer (25
mM Hepes-KOH, pH 7.2, 125 mM potassium acetate, 2.5 mM magnesium
acetate) or with microtubule stabilizing buffer (MSB; 80 mM Pipes-KOH,
pH 6.8, 5 mM EGTA, 1 mM MgCl
 
2
 
 containing 0.5% Triton X-100)
 
 
 
for 5
min at room temperature before fixing with chilled absolute methanol for
10 min at 
 
2
 
20
 
8
 
C as described (Terada et al., 1998). After being washed,
cells were incubated with the following antibodies: rabbit anti-zyxin
antibody, rat anti–h-warts antibody (G3), and monoclonal mouse anti–
 
a
 
-tubulin antibody (B512). This was followed by incubation with FITC-
conjugated anti–rabbit/mouse IgG antibody (Amersham Pharmacia),
Cy3-conjugated anti-rat IgG antibody (Amersham Pharmacia), and
Texas  red–conjugated anti-mouse IgG antibody (Molecular Probes). The
 
stained cells were mounted with 1,4-diazabicyclo-[2,2,2]-octane/glycerol,
and observed with confocal microscopy (Fluoview; Olympus). Images
were obtained separately by independent excitation at 488/568 nm to min-
imize overlapping signals, and were processed using Photoshop software
(Adobe).
 
Microinjection
 
U2OS cells were grown on 35-mm petri dishes to 75% confluency and mi-
croinjected using semi-automatic micro-manipulator/injector (Eppendorf
5171/5246). Cells in prometaphase were selected for injection on the basis
of morphology by phase contrast images, and injected with a 1.0 mg/ml so-
lution of purified GST fusion proteins and rhodamine-tubulin (Cytoskele-
ton) in PBS, pH 6.9, supplemented with a final concentration of 0.5 mM
GTP. The microscopical stage was maintained at 37
 
8
 
C and the procedure
was completed within 20 min to minimize pH changes. After injection,
cells were incubated at 37
 
8
 
C for 20 min for rhodamine-tubulin to be dis-
tributed to the mitotic spindle, followed by detergent preextraction (7.5
 
m
 
g/ml digitonin in KHM buffer) and a methanol fixation protocol as de-
scribed above.
Synchronized HeLa cells were injected into the cytoplasm with a combina-
tion of 1.0 mg/ml solution of purified GST fusion proteins together with
1.0 mg/ml 
 
b
 
-galactosidase (Sigma-Aldrich). Cells were fixed with 0.5% glu-
taraldehyde/PBS, pH 7.2, at subsequent time points, followed by incuba-
tion with 1 mg/ml of 5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
D
 
-galactopyranoside
(X-gal) in 150 mM NaCl, 0.01% sodium deoxycholate, 0.02% NP-40, 2 mM
MgCl
 
2
 
, 5 mM K
 
3
 
Fe(CN)
 
6
 
, and 5 mM K
 
4
 
Fe(CN)
 
6
 
 for 12 h at 37
 
8
 
C. After re-
moving the X-gal solution, cells were overlaid with acreto-orcein (Merck)
in 60% acetic acid to visualize chromatin.
 
Results
 
Identification of h-warts/LATS1 Interacting Protein
 
To identify proteins that physically interact with h-warts/
LATS1, we conducted a HeLa cDNA library screen by the
yeast two-hybrid method. We used a region of amino acids
394–675, which does not contain the kinase domain of
h-warts/LATS1, as the bait for the screen (Fig. 1 A). From
2.3 
 
3 
 
10
 
6
 
 initial transformants, 53 clones were found to
confer both the His
 
1
 
 and LacZ
 
1
 
 phenotypes on L40 con-
taining pBTM116HA/h-warts. These positive clones were
subjected to secondary screening to eliminate false posi-
tives, and confirmed the specific interaction between
h-warts/LATS1 and protein encoded by a library cDNA
within the yeast cells. Among the positive clones, we iso-
lated four independent cDNA clones encoding partial pro-
tein fragments that derived from zyxin, a regulator of actin
assembly (Fig. 1 A). The other h-warts/LATS1-interacting
proteins identified in this screen will be described else-
where.
 
Interaction of Zyxin with h-warts/LATS1
 
To examine whether zyxin interacts with h-warts/LATS1
in intact cells, we coexpressed zyxin with h-warts/LATS1
in COS7 cells (Fig. 1 B). Full-length zyxin and full-length
h-warts/LATS1 were tagged with FLAG and HA epi-
topes, respectively, at their NH
 
2
 
 termini. When the lysate
coexpressing FLAG-zyxin with HA-h-warts/LATS1 was
immunoprecipitated with the anti-FLAG antibody, HA-
h-warts/LATS1 was detected in the FLAG-zyxin immune
complex (Fig. 1 C, lane 1). Conversely, FLAG-zyxin was
detected in the HA-h-warts/LATS1 immune complex (Fig.
1 C, lane 4). Neither FLAG-zyxin nor HA-h-warts/LATS1
was detected in the unrelated control IgG immunoprecipi-
tates from lysates expressing both proteins (data not
shown). 
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An additional experiment to confirm the interaction of
zyxin with h-warts/LATS1 was performed. Two polyclonal
antibodies were raised against h-warts/LATS1 by injecting
two KLH-conjugated synthetic polypeptides, C1 (amino
acids 1,041–1,063) and C2 (amino acids 1,111–1,130), into
rabbits. Endogenous h-warts/LATS1 was immunoprecipi-
tated by the anti-C1 antibody and was detected at immu-
noblotting by the anti-C2 antibody (Fig. 1 D, lane 8).
When the COS7 cell lysate expressing HA-tagged zyxin
(full-length) was immunoprecipitated with the anti-C1 an-
tibody, HA-zyxin (full-length) was coprecipitated with en-
dogenous h-warts/LATS1 (Fig. 1 E, lane 3).
Furthermore, we tested whether endogenous zyxin and
h-warts/LATS1 interact in vivo. Using anti-zyxin antibody
generated in rabbits, zyxin was immunoprecipitated from
HeLa cell lysate. The endogenous h-warts/LATS1 was de-
tected in the immunoprecipitate (Fig 1 F). Although com-
parison of the band profiles revealed that the small frac-
tion of h-warts/LATS1 (
 
z
 
9%) interacts with zyxin, these
results indicate the association of h-warts/LATS1 and
zyxin in intact cells.
Since zyxin harbors three copies of LIM domain in the
COOH-terminal third of the molecule (Fig. 2 A), known
as a protein–protein interacting structure, we first exam-
ined whether the LIM domain of zyxin serves as a binding
interface for h-warts/LATS1 interaction. COS7 cell lysates
Figure 1. Interaction of zyxin with
h-warts/LATS1. (A) Schematic dia-
gram of human h-warts/LATS1 and
human zyxin showing their domain
structures. The hatched bar below
the h-warts/LATS1 structure repre-
sents the portion used as the bait in
the two-hybrid system. Four bold-
face lines below the human zyxin
structure indicate the portions of
zyxin encoded by cDNA clones re-
covered in the two-hybrid screening.
(B) Expression of HA-tagged
h-warts and FLAG-tagged zyxin in
COS7 cells. The lysates (15 mg of
protein) expressing both HA-tagged
h-warts and FLAG-tagged zyxin
were probed with the anti-HA or
anti-FLAG antibodies. The lysates
of COS7 cells transfected with
empty vectors were used as controls.
(C) Interaction of zyxin with
h-warts/LATS1 in COS7 cells. The
same lysates (200 mg of protein) of
COS7 cells prepared in (A) were
immunoprecipitated with the anti-
HA antibody or the anti-FLAG an-
tibody. The immunoprecipitates
were probed with anti-HA or anti-
zyxin antibodies. (D) Specificity of the h-warts/LATS1 antibody. Lysates of COS7 cells expressing HA-tagged h-warts (lanes 1 and 5),
HeLa cell lysate (lane 2), and HeLa cell lysate immunoprecipitated with preimmune IgG (lanes 3 and 7) or with the anti-C1 antibody
(lanes 4 and 8) were immunoblotted by preimmune IgG (lanes 1–4) or by the anti-C2 antibody (lanes 5–8). Arrow indicates endoge-
nous h-warts/LATS1. (E) Endogenous h-warts/LATS1 interacts with zyxin. The lysate of COS7 cells expressing HA-tagged zyxin (full-
length) was immunoprecipitated with the anti-C1 antibody (lane 3), or with preimmune IgG (lane 2). The immunoprecipitates were
probed with the anti-HA antibody. (F) Coimmunoprecipitation of endogenous h-warts/LATS1 and zyxin. The lysate of HeLa cells was
immunoprecipitated with preimmune IgG or with the anti-zyxin antibody generated in rabbits as described in Fig. 3. Equal amount of
cell lysate was immunoprecipitated with anti–h-warts/LATS1 antibody to quantify the endogenous protein in the aliquot of lysate (in-
put). The immunoprecipitates were probed with the rat anti–h-warts/LATS1(G4) antibody (upper), and the goat anti-zyxin antibody
(lower), as indicated. 
Hirota et al. 
 
Mitosis-specific Interaction of h-warts and Zyxin
 
1077
 
expressing HA-tagged zyxin either full-length, NH
 
2
 
-termi-
nal two-thirds (
 
D
 
1) or COOH-terminal third (
 
D
 
2), which
contains three LIM domains, were incubated with GST–
h-warts/LATS1 (amino acids 136–700) fusion protein bound
to glutathione-agarose beads (Fig. 2 B, lanes 1–3). The
pull-down assay revealed that HA-zyxin
 
D
 
2 coprecipitated
with GST–h-warts/LATS1 but HA-zyxin
 
D
 
1 did not (Fig. 2
B, lanes 7 and 9). Unexpectedly, the full-length HA-zyxin
was hardly detectable in the GST–h-warts precipitate (Fig.
2 B, lane 5).
We next sought to delineate in detail the region(s) of
zyxin important for its association with h-warts/LATS1 us-
ing GST fusion proteins containing a full-length or various
truncated zyxin (Fig. 2 A). Same amounts of GST-zyxin
fusion proteins bound to glutathione-agarose beads were
incubated with baculoviral expressed His-tagged h-warts
(full-length), and the retained proteins were analyzed by
immunoblotting with anti-C2 antibody. While GST-zyxin-
LIM1/2 (
 
D
 
3) and GST-zyxin-LIM1/2/3 (
 
D
 
2) were found to
bind with purified h-warts protein, the other GST-zyxin
mutants did not (Fig. 2 C). This in vitro binding experi-
ment demonstrated that zyxin directly interacts with
h-warts/LATS1 and that the region containing both LIM1
and LIM2 domains of zyxin is essential for their binding.
Interestingly, consistent with the findings shown in Fig.
2 A, GST-zyxin (full-length) did not interact with His-
tagged h-warts/LATS1. However, their association was
detected in in vivo binding assays (Fig. 1, C, E, and F).
Based on these findings, we speculated that the LIM1/2
 
domains are masked in full-length zyxin and that an in-
tramolecular and/or intermolecular modification may reg-
ulate the interaction between zyxin and h-warts/LATS1.
 
Localization of h-warts/LATS1–Zyxin Complex to 
Mitotic Apparatus
 
Next, we compared the subcellular localization of h-warts/
LATS1 and zyxin by immunocytochemical analysis. We
raised antibody against zyxin (amino acids 24–35) in rab-
bits by the procedure described by Macalma et al. (1996).
Consistent with their previous characterization, this an-
tibody recognized a single band of z82 kD, which is
described as the molecular mass of full-length zyxin by
immunoblotting (Fig. 3 A). Indirect immunofluorescent
studies revealed that the antibody specifically detected
concentrated zyxin at the focal adhesion plaques, where
the bundles of actin filaments end (Fig. 3 B). In the mitotic
cells, the characteristic staining of zyxin was found to dis-
appear from focal adhesions and was seen as a diffuse cy-
toplasmic distribution (Fig. 3 C). A similar change in sub-
cellular distribution was observed in vinculin, another
focal adhesion protein with a proline-rich stretch function-
ally related to zyxin, as cells retracted and rounded up dur-
ing mitosis (data not shown). Notably, with careful obser-
vation of the zyxin immunostaining, a zyxin signal was
barely seen at the mitotic apparatus (Fig. 3 C, b, arrows).
This signal became more distinct when cells were fixed
with acetone/methanol solution (Fig. 3 D).
Figure 2. In vitro interaction
of h-warts/LATS1 and zyxin.
(A) Schematic diagram of
deletion mutant zyxin show-
ing their domain structures.
The NH2-terminal two-thirds
mutant (D1) contains four
copies of a proline rich clus-
ter and the nuclear exporting
signal (NES), and the
COOH-terminal third mu-
tant (D2) contains three cop-
ies of the LIM domain. LIM
domains were constructed
tandemly or independently
as indicated (D3–D7). The
HA-tag epitope or the GST
region of the fusion protein is
not shown. (B) The lysates
of COS7 cells expressing
the indicated HA-tagged
zyxin full-length and mutants
(lanes 1–3) were subjected to
incubation with either GST
alone (lanes 4, 6, and 8) or
GST–h-warts/LATS1 (amino
acids 136–700) resin (lanes 5,
7, and 9). The bound fraction
was analyzed by SDS-
PAGE, followed by immunoblotting with anti-HA antibody. (C) In vitro binding assay between recombinant h-warts/LATS1 and
zyxin. 10 mg of the purified GST-zyxin deletion mutants, as shown in (A), were immobilized to resins, and incubated with purified His-
tagged h-warts/LATS1 (1.0 mg of protein) generated in baculovirus-infected Sf9 cells. The bound fraction was analyzed by immunoblot-
ting with the anti-C2 antibody.The Journal of Cell Biology, Volume 149, 2000 1078
To examine localization in detail, cells were processed in
a detergent-preextraction protocol which washes out the
free cytoplasmic proteins. As previously reported, h-warts/
LATS1 locates to centrosomes during interphase (Fig.
4 A, a–c). When cells enter prometaphase/metaphase,
h-warts/LATS1 translocates toward the mitotic spindle ar-
ray as well as the spindle poles (Fig. 4 A, d–f). As the cell
commits to anaphase (Fig. 4 A, g–i) and later to telophase
(Fig. 4 A, j–l), h-warts/LATS1 is found progressively at the
bundle of microtubules at the midzone, called the central
spindle, that connects daughter cells (Fig. 4 A, m–o). The
detergent-preextraction immunostaining procedure showed
that a fraction of zyxin was also found to associate with mi-
totic apparatus during mitosis. As cells entered mitosis,
when assembly of the mitotic spindle begins from spindle
poles, zyxin initially located to the mitotic spindle (Fig. 4
B, a–c), and this association with the mitotic spindle be-
came prominent by metaphase (Fig. 4 B, d–f). As cells pro-
ceeded into anaphase, zyxin was detected on the spindle
between segregated sister chromatids, which are com-
posed of bidirectional overlapping polar spindle (Fig. 4 B,
g–i). In late anaphase, zyxin became detectable as a dis-
tinct wide band extending across the midzone of the cen-
tral spindle (Fig. 4 B, j–l). This central spindle staining per-
sisted into telophase when the spindle compacts into the
midbody (Fig. 4 B, m–o). These specific staining patterns
on the mitotic apparatus were neither detected with the
preimmune IgG nor with anti-vinculin antibody (data not
shown). When cells were double-stained for h-warts/
LATS1 and zyxin, the yellow color produced by superim-
Figure 3. Specificity of the anti-zyxin antibody. (A) Total lysates of HeLa cells (lanes 1 and 3), and U2OS cells (lanes 2 and 4) were re-
solved in 12% SDS-PAGE, followed by immunoblotting with either the preimmune IgG (lanes 1 and 2) or the anti-zyxin antibody
(lanes 3 and 4). (B) Subcellular localization of endogenous zyxin. Subconfluently grown U2OS cells were fixed with 4% paraformalde-
hyde and processed for indirect immunofluorescent staining with the anti-zyxin antibody labeled by FITC. DNA was visualized by pro-
pidium iodide (a), and F-actin by rhodamine-phalloidin (b). (C) Distribution of zyxin during the cell cycle. U2OS cells were prepared as
in (B, a). Representative cells in prophase (a), metaphase (b), anaphase (c), and telophase (d) are shown. (D) Detection of zyxin on the
mitotic apparatus. U2OS cells were fixed with acetone/methanol solution and processed for immunostaining with the anti-zyxin anti-
body labeled with FITC (a and d) and anti-tubulin antibody labeled with Cy3 (b and e). The merged picture of the left two panels are
shown in the right panel (c and f). Representative cells in metaphase (a–c) and telophase (d–f) are shown. Bars, 10 mm.Hirota et al. Mitosis-specific Interaction of h-warts and Zyxin 1079
posing green and red demonstrated that h-warts/LATS1
and zyxin colocalize on the mitotic spindle, spindle poles
and midbody of the dividing cells (Fig. 4 C). The dynamic
changes in zyxin and h-warts/LATS1 localization on the
mitotic apparatus is identical, suggesting that zyxin inter-
acts with h-warts/LATS1 on the mitotic apparatus, includ-
ing mitotic spindle and central spindle at midzone of the
dividing cells.
Specific Phosphorylation of Zyxin during Mitosis
Since h-warts/LATS1 was reported to be posttranslation-
ally modified in a cell cycle–specific manner and to play a
critical role in cell cycle regulation (Tao et al., 1999; Nish-
iyama et al., 1999), we asked whether zyxin also has any
cell cycle phase-specific changes concomitant with that of
h-warts/LATS1 protein. For cell cycle analysis, HeLa cells
were synchronized at the beginning of S phase by double
thymidine block method. At different times after release
from block, cells were harvested and analyzed for zyxin by
immunoblotting with anti-zyxin antibody (Fig. 5 A). Al-
though levels of zyxin expression did not change through-
out the cell cycle, a slow-migrating form of zyxin appeared
in cells at 9 and 10 h after release from S phase, where con-
siderable number of cells were in the mitotic phase as
monitored by cyclin B protein level (Fig. 5 A, lanes 4 and
5). This slow migrating band became prominent when cells
were treated with the microtubule-depolymerizing agent,
nocodazole (Fig. 5 A, lane 8), whereas vinculin protein re-
mained stable throughout cell cycle. To test whether this
mitosis-specific modification of zyxin is phosphorylation,
we examined the effect of phosphatase treatment on the
mobility shift. The slow-migrating bands found in the mi-
totic and nocodazole-treated cell lysates were converted
into the fast-migrating bands after zyxin was incubated
with calf intestine alkaline phosphatase (Fig. 5 B, lanes 4
and 6). These results indicate that the slow-migrating form
is phosphorylated zyxin, and that zyxin is specifically phos-
phorylated during mitosis.
For an additional approach to demonstrate the specific
phosphorylation of zyxin during mitosis, in vitro kinase as-
say using cell lysates was employed. We used cell lysates
from various phases in the cell cycle as sources of the en-
zyme and GST-zyxin as the substrate. GST-zyxin was phos-
phorylated significantly with mitotic cell lysate (Fig. 5 C,
lane 3). To determine the phosphorylation region(s) in the
molecule GST-zyxinD1 and GST-zyxinD2 were processed
for the in vitro kinase assay. GST-zyxinD1, which corre-
sponds to the NH2-terminal two thirds of zyxin, was signif-
icantly phosphorylated with mitotic cell lysate whereas no
phosphorylation was detected in GST-zyxinD2 (Fig. 5 D).
Characterization of Zyxin-Kinase during Mitosis
To address the class to which zyxin-kinase belongs, we
used various specific inhibitors that have been developed
for kinases. The kinase assay was performed with mitotic
cell lysates which were preincubated with various kinase
inhibitors (Fig 6 A). GST-zyxin phosphorylation activity in
the cell lysate was specifically inhibited not only when the
mitotic cell lysate was preincubated with the broad serine/
threonine kinase inhibitor staurosporine (100 nM), but also
after preincubation with olomoucine, which is a specific in-
hibitor of Cdc2 (Fig. 6 A). Therefore, to examine whether
Cdc2 kinase is the responsible kinase for zyxin phosphory-
lation in the mitotic cell lysate, we prepared mitotic cell ly-
sate depleted of Cdc2, which should contain the full com-
plement of mitotically active kinases except for Cdc2,
including kinases activated downstream of Cdc2 (Fig. 6 B).
By monitoring the total protein concentration and the
Cdc2 kinase activity of the depleted mitotic cell lysate
(Fig. 6 C), we found that phosphorylation of GST-zyxin
was significantly inhibited by depleting Cdc2 from the mi-
totic cell lysate (Fig. 6 D, lane 3). Addition of active Cdc2
complex to the Cdc2-depleted mitotic cell lysate restored
the phosphorylation activity (Fig. 6 D, lane 4), indicating
that loss of zyxin phosphorylating activity was due to re-
moval of Cdc2 but not to other components in the lysate.
Furthermore, the purified Cdc2 kinase complex was suffi-
cient for zyxin phosphorylation without requiring any
other components (Fig. 6 E). These data demonstrate that
Cdc2 is a kinase responsible for the mitosis-specific phos-
phorylation of zyxin in vitro, even though other active ki-
nases are present in the mitotic lysate.
Phosphorylation of Zyxin by Cdc2 Regulates Binding
to h-warts/LATS1
Three lines of evidence suggest that zyxin interacts with
h-warts/LATS1 during mitosis and that the interaction is
regulated by the phosphorylation of zyxin. First, zyxin
undergoes posttranslational modification during mitosis,
which was shown to be phosphorylation. Second, h-warts/
LATS1 binds to the region containing LIM1 and LIM2 do-
mains of zyxin and an intra/inter-molecular modification
of zyxin may be required for h-warts/LATS1 to access to
the binding domains. Third, a fraction of zyxin is distrib-
uted to the mitotic apparatus, where it colocalizes with
h-warts/LATS1 protein. Since our results demonstrated
that Cdc2 is the kinase responsible for mitotic phosphory-
lation of zyxin, we postulated that the Cdc2-mediated
phosphorylation of zyxin promotes interaction between
zyxin and h-warts/LATS1. To test this possibility, GST-
zyxin (full-length) was phosphorylated by active Cdc2
complex, followed by incubation with recombinant His-
tagged h-warts/LATS1. His-tagged h-warts/LATS1 precipi-
tated with phosphorylated GST-zyxin (Fig. 7 A, lane 5)
while the control unphosphorylated GST-zyxin did not
(Fig. 7 A, lanes 2 and 4).
Furthermore, to examine whether zyxin associates with
h-warts/LATS1 specifically during mitosis in the intact
cells, endogenous zyxin was immunoprecipitated from
either interphase or mitotic cell lysate and probed with
anti–h-warts/LATS1 antibody. The endogenous h-warts/
LATS1 coprecipitated with zyxin from mitotic lysate was
found to be more abundant than that from interphase cell
lysate (Fig. 7 B, lane 4). These results indicates that zyxin
interacts with h-warts/LATS1 during mitosis, and that the
interaction is regulated by phosphorylation of zyxin. This
mitosis-specific interaction explains why the proportion of
the zyxin-binding h-warts/LATS1 to its entire pool was
less than 10% in asynchronized cells (Fig. 1 F). It is also in-
teresting to note that the zyxin-binding h-warts/LATS1
migrated slower than its entire pool (Fig. 1 F), suggest-
ing that mitotic phosphorylated form of h-warts/LATS1The Journal of Cell Biology, Volume 149, 2000 1080
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(Nishiyama et al., 1999; Tao et al., 1999) preferentially in-
teracts with zyxin.
Zyxin Is Targeted to the Mitotic Apparatus by 
Interacting with h-warts/LATS1
To test whether dynamic changes in zyxin localization on
the mitotic apparatus is dependent on h-warts/LATS1 dis-
tribution, we attempted to disrupt endogenous zyxin local-
ization by injecting excessive amounts of an h-warts/
LATS1 fragment (amino acids 136–700) that is shown to
bind preferentially to zyxin (Fig. 2 B). Prophase/pro-
metaphase U2OS cells were microinjected with purified
GST–h-warts/LATS1(136–700) fusion protein, or control
GST protein. Rhodamine-labeled tubulin was injected to-
gether with the GST fusion proteins not only to distinguish
injected cells but to monitor mitotic spindle organization
as the cell cycle proceeds. After injection, cells were sub-
jected to the detergent-preextraction immunostaining with
anti-zyxin antibody. Signal of endogenous zyxin on the mi-
totic apparatus was diminished or disappeared in 64% of
the GST–h-warts/LATS1(136–700)–injected cells (n 5 11),
whereas it was decreased in only 18% of the GST-injected
control cells (n 5 12; Fig. 8). These observations indicate
that association of zyxin with h-warts/LATS1 is essential
for targeting as well as dynamic localization of zyxin on
the mitotic apparatus during mitosis.
Biological Significance of h-warts/LATS1-Zyxin 
Complex on the Mitotic Apparatus
Since h-warts/LATS1 is speculated to be involved in mi-
totic control, the h-warts/LATS1-zyxin complex on the mi-
totic apparatus may play a role in proper execution of
the mitotic process. To test this possibility, we examined
whether h-warts/LATS1(136–700) microinjected cells can
proceed through mitosis normally. HeLa cells, synchro-
nized at S phase, were coinjected with GST–h-warts/
LATS1 (136–700) or GST-mock and b-galactosidase to de-
tect injected cells. Cells were fixed at various time points
after release from an S phase block, and the frequency of
mitotic cells (mitotic index) in cells having b-galactosidase
activity was determined (Fig. 9 A). While the control ex-
periments exhibited a peak mitotic index at 10.5 h after re-
lease from S phase and a decrease after 12 h, h-warts/
LATS1(136–700)–injected cells revealed a high mitotic
index after 10.5 h and continued to increase until 12 h after
the release (Fig. 9 B). Apparently, cells injected with h-warts/
LATS1(136–700) had a prolonged mitotic phase. These
observations suggest that disruption of h-warts/LATS1-
zyxin complex leads to impairment of normal mitotic pro-
gression.
Discussion
In searching for cellular targets of the h-warts/LATS1 tu-
mor suppressor protein, we have identified zyxin which
plays a central role in actin assembly and organization.
During interphase, zyxin is found at cellular locations that
are enriched in actin filaments, including the leading edge
and focal adhesion plaques, whereas h-warts/LATS1 is lo-
calized to centrosome. However, during mitosis, when
zyxin is dissociated from focal adhesions, a fraction of the
free cytoplasmic zyxin becomes associated with mitotic
spindles. We have shown that zyxin is phosphorylated dur-
ing mitosis and that the mitotic phosphorylation is re-
quired for association with h-warts/LATS1 on the mitotic
Figure 4. Colocalization of zyxin and h-warts/
LATS1 to the mitotic apparatus. (A) Local-
ization of h-warts/LATS1 at the different
phases of the cell cycle. U2OS cells were pre-
extracted with MSB (microtubule stabilizing
buffer, including 0.5% Triton X-100) and
fixed with cold methanol, followed by incuba-
tion with rat anti–h-warts antibody and
mouse anti–a-tubulin antibody. Immunofluo-
rescence staining was performed with FITC-
conjugated anti–mouse IgG antibody (a, d, g,
j and m) and Cy3-conjugated anti–rat IgG an-
tibody (b, e, h, k, and n). The merged pictures
of the upper two panels are shown in the
lower panel (c, f, i, l, and o). Representative
cells in interphase (a–c), metaphase (d–f),
anaphase (g–i), telophase (j–l), and later telo-
phase (m–o) are shown. (B) Distribution of
zyxin during mitosis. U2OS cells were preex-
tracted with 7.5 mg/ml digitonin/KHM, and
fixed with cold methanol, after incubation
with rabbit anti-zyxin antibody and mouse
anti–a-tubulin antibody. Immunofluorescence staining was performed with Texas red–conjugated anti–mouse IgG antibody (a, d, g, j,
and m) and FITC-conjugated anti–rabbit IgG antibody (b, e, h, k, and n). The merged pictures of the upper two panels are shown in
the lower panel (c, f, i, l, and o). Representative cells in prometaphase (a–c), metaphase (d–f), anaphase (g–i), telophase (j–l), and later
telophase (m–o) are shown. (C) Identical distribution of h-warts/LATS1 and zyxin to the mitotic apparatus. U2OS cells were prepared
and fixed as in (A) and processed for incubation with rabbit anti-zyxin antibody (a and d) and rat anti–h-warts antibody (b and e). Im-
munofluorescence staining was performed with FITC-conjugated anti–rabbit antibody and Cy3-conjugated anti–rat IgG antibody. The
merged pictures of the left two panels are shown in the right panel (c and f). Bars, 10 mm.The Journal of Cell Biology, Volume 149, 2000 1082
apparatus. These findings implicate dual functions for
zyxin: not only does it play a key role in cell adhesion and
cytoskeletal organization in interphase cells, but it also
acts as a participant in mitotic control by forming a com-
plex with h-warts/LATS1 on the mitotic apparatus.
Regulation of the Interaction between h-warts/LATS1 
and Zyxin
We have shown a physical association of zyxin with
h-warts/LATS1 and that a region containing the first and
second LIM domains (LIM1/2) of zyxin is responsible for
the interaction. The LIM domain is a protein binding mo-
tif which is found in a wide variety of proteins involved in
transcription, cell adhesion, and cytoskeletal organization
(Schmeichel and Beckerle, 1994; Dawid et al., 1998). Pro-
teins with multiple LIM domains, such as zyxin, are con-
sidered to function as scaffolds for the assembly of protein
complexes. To date, only cysteine-rich protein 1 (CRP1)
has been reported to associate with the LIM1 domain of
zyxin (Sadler et al., 1992). Our findings demonstrated that
a combination of LIM1 and LIM2 domains, but not that of
LIM2 and LIM3, is essential for zyxin to interact with
h-warts/LATS1, suggesting that a specific protein recogni-
tion mechanism is used for their interaction. The associa-
tion of h-warts/LATS1 with the full-length zyxin has been
detected by in vivo but not by in vitro  binding experi-
ments. However, the deletion of the NH2-terminal region
of zyxin has allowed the LIM1/2 domain to interact with
h-warts/LATS1 in vitro. Therefore, we speculate that the
LIM1/2 domains are masked in full-length zyxin and that
the posttranslational modification, such as phosphoryla-
tion and/or proteolysis, gives rise to the conformational
alterations in zyxin, exposing the LIM domains on the
surface of the molecule, which allows h-warts/LATS1 to
approach.
Although zyxin was first described as a phosphoprotein
(Crawford and Beckerle, 1991), both the mechanism and
the biological significance of the phosphorylation have re-
mained elusive. In this study, we demonstrated that the
NH2-terminal region of zyxin is mitotically phosphory-
lated. Three lines of evidence presented here suggest that
the mitotic phosphorylation of zyxin is mediated by Cdc2,
a primary kinase to drive mitosis. First, depletion of Cdc2
from mitotic cell lysates completely abolished phosphory-
lation of zyxin. Second, purified active Cdc2 complex
phosphorylated zyxin. Third, zyxin is phosphorylated dur-
ing mitosis when Cdc2 is active. A number of studies have
focused on the role of Cdc2 in the coordination of cellular
and biochemical events during mitosis, and identification
Figure 5. Mitosis-specific
phosphorylation of zyxin. (A)
Posttranslational modifica-
tion of zyxin during the cell
cycle. HeLa cells were syn-
chronized at the beginning of
S phase by the double thymi-
dine block method. After re-
lease from S phase, cells were
harvested at the indicated
time points (lanes 1–7). To
block cells at mitosis, nocoda-
zole was added into the me-
dium 6 h after release from S
phase and incubated for an-
other 6 h (N, lane 8). After
removal of nocodazole, cells
were incubated in nocoda-
zole-free media for another
3 h to obtain interphase cells
(NR, lane 9). Samples were
analyzed for DNA content by
flow cytometry. The percent-
ages of the cells in G1, S, and
G2/M are shown in the upper
panel. Each sample was sub-
jected to immunoblotting
with anti-zyxin antibody,
anti-vinculin antibody, and
anti-cyclin B antibody. (B) Phosphatase treatment of zyxin. Endogenous zyxin was immunoprecipitated from interphase (lanes 1 and 2),
mitotic (lanes 3 and 4) and nocodazole-treated (lanes 5 and 6) lysate and incubated with 100 units of calf intestine alkaline phosphatase
(CIAP) (lanes 2, 4, and 6) or without CIAP (lanes 1, 3, and 5) at 378C for 30 min. Equal amount of precipitants were immunoblotted
with the anti-zyxin antibody. Arrows indicate the endogenous zyxin. (C) Detection of zyxin-kinase activity in mitotic cell lysate. GST-
zyxin (full-length) was incubated in the presence of g-[32P]ATP with either buffer alone (lane 1), interphase cell lysate (lane 2), or mi-
totic cell lysate (lane 3) for 30 min at 258C. GST-zyxin (full-length) was analyzed by SDS-PAGE and autoradiography. (D) Phosphory-
lation region of zyxin. Purified GST-zyxin, full-length and truncated mutants, as indicated (left; Coomassie blue staining), were
subjected to in vitro kinase assay with interphase/mitotic cell lysate as described in (C) (right, autoradiography). Note that a fraction of
protein was converted into the slow-mobility form after incubation with mitotic lysate in GST-zyxin (full-length) and zyxinD1.Hirota et al. Mitosis-specific Interaction of h-warts and Zyxin 1083
of its physiological substrates continues to represent a ma-
jor challenge (Nigg et al., 1996; Nurse, 2000). It cannot be
completely ruled out the possibility that another kinase
phosphorylates zyxin in vivo. However, the previous find-
ings that a fraction of the cellular pool of Cdc2 is asso-
ciated with the mitotic spindle, where it forms an active
kinase complex with cyclin B (Bailly et al., 1989), also sup-
ports our present observations.
As predicted by our hypothesis, the Cdc2-dependent
phosphorylation has been shown to allow the full-length
zyxin to interact with h-warts/LATS1 (Fig. 7 A). In fact,
zyxin associates with h-warts/LATS1 preferentially dur-
ing mitosis (Fig. 7 B), and this interaction might be signif-
icant for the subsequent cellular events in cell division.
However, the binding of phosphorylated full-length zyxin
to h-warts/LATS1 was not as efficient as that of the D2
protein (Fig. 7 A), so the possibility can not be excluded
that the interaction is regulated by not only phosphory-
lation but other unknown modifications of full-length
zyxin.
Spatial Control of Zyxin Localization during Mitosis
Zyxin has been shown to dissociate from focal adhesion
plaques and to distribute diffusely into the cytoplasm coin-
cidentally with the mitotic disappearance of focal adhe-
sions. Subsequently, a fraction of this free cytoplasmic
zyxin becomes colocalized with h-warts/LATS1 on the mi-
totic apparatus (Figs. 3 and 4). Since zyxin plays a critical
role in the actin filament assembly at focal adhesions
(Beckerle, 1998, 1997), dissociation of zyxin may contrib-
ute to actin stress fiber disassembly in the mitotic cells.
The other focal adhesion components, such as paxillin
(Yamaguchi et al., 1997) and p130CAS (Yamakita et al.,
1999), have been reported to be phosphorylated during
mitosis when focal adhesions dissociate. As for zyxin, it
can be speculated that the mitotic phosphorylation is a sig-
nal for triggering detachment of zyxin from adhesion sites.
However, two observations presented here support the
possibility that mitotic phosphorylation is required mainly
to recruit zyxin to the mitotic spindle. First, although most
of the zyxin became dissociated during mitosis, both phos-
phorylated and dephosphorylated zyxin were detected in
the cells at mitosis (Fig. 5, A and B). Second, the immu-
nolocalization study demonstrated that a subfraction of
zyxin localized to the mitotic apparatus (Fig. 3, C and D),
which was clearly detected by the preextraction method
(Fig. 4 B).
Figure 6. Characterization of
zyxin-kinase. (A) Effect of
protein kinase inhibitors on
the zyxin-kinase activity in
mitotic cell lysate. GST-zyxin
(full-length) was incubated
for 30 min at 258C in the
presence of g-[32P]ATP and
mitotic cell lysate with the
indicated protein kinase in-
hibitors as follows: 100 nM
staurosporine (broad serine/
threonine kinase inhibitor),
100 mM olomoucine (Cdc2
inhibitor), 100 mM U0126
(MEK1 inhibitor), 1 mM PKI
(protein kinase A inhibitor),
100 nM calphostin C (protein
kinase C inhibitor), 100 mM
SB203580 (p38 kinase inhibi-
tor), or without kinase inhibi-
tor (mitotic cell lysate alone).
Results are presented as the
percentage of the levels of
GST-zyxin phosphorylation,
where 100% represents the
phosphorylation level after incubation with mitotic cell lysate alone. (B) Depletion of Cdc2 from mitotic cell lysate. Mitotic cell lysate
(lane 1) was incubated with p13-suc1–conjugated agarose beads to deplete Cdc2 (lanes 2 and 4). Mock depletion was performed by incu-
bating the mitotic cell lysate with the same volume of unconjugated agarose beads (lanes 3 and 5). Unbound cytosolic proteins were im-
munoblotted with anti-Cdc2 (top) or anti–b-tubulin antibodies (bottom). (C) Histone H1 kinase activity of mitotic cell lysates. The
peptide derived from histone H1 was incubated in the presence of g-[32P]ATP with mitotic cell lysate, mock-depleted lysate, or
Cdc2-depleted lysate. Results are presented as percentage of the phosphorylation levels of the peptide, where 100% represents the
phosphorylation level after incubation with the mitotic cell lysate. (D) Effect of Cdc2 depletion on the zyxin-kinase activity in mitotic
cell lysate. GST-zyxin (full-length) was incubated in the presence of g-[32P]ATP with either buffer alone (lane 1), mock-depleted mitotic
cell lysate (lane 2), or Cdc2-depleted mitotic cell lysate (lane 3), or Cdc2-depleted mitotic cell lysate supplemented with purified active
Cdc2 complex (lane 4) for 30 min at 258C. GST-zyxin (full-length) was analyzed by SDS-PAGE and autoradiography. (E) Direct phos-
phorylation of zyxin by Cdc2. GST-zyxin (full-length) was incubated in the presence of g-[32P]ATP with (lane 1) or without active Cdc2
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Dynamic Interaction of h-warts/LATS1–Zyxin Protein 
Complex on the Mitotic Apparatus
The interaction between zyxin and h-warts/LATS1 on the
mitotic apparatus implicates a significant role of actin reg-
ulatory proteins during mitosis. Zyxin serves as a scaffold
for gathering actin regulatory proteins, such as Ena/
VASP–profilactin complex or vav-small GTPase complex,
at focal adhesion plaques (Beckerle, 1997). In fission yeast
Figure 7. Regulation of h-warts/
LATS1-zyxin association. (A) As-
sociation of h-warts/LATS1 with
Cdc2-mediated phosphorylation of
zyxin. 10 mg of GST-zyxin (full-
length) was incubated with active
Cdc2 complex with or without ATP
for 30 min at 258C as described in
Fig. 6 E, followed by in vitro bind-
ing assay as in Fig. 2 C. After kinase
reaction in the absence of ATP
(lane 4), or in the presence of ATP
(lane 5), GST-zyxin (full-length)
were incubated with 1 mg of His-
tagged h-warts/LATS1 (lane 1).
Control experiments were per-
formed without kinase reaction us-
ing GST-zyxin (full-length) (lane 2) or GST-zxyinD2 (lane 3). Bound fraction was analyzed by SDS-PAGE, followed by immunoblot-
ting with the anti-C2 antibody. (B) Mitosis-specific interaction of h-warts/LATS1 and zyxin. The lysate of interphase (lanes 1 and 2) or
mitotic (lanes 3 and 4) HeLa cells was immunoprecipitated with preimmune IgG (lanes 1 and 3) or with the anti-zyxin antibody (lanes 2
and 4). The immunoprecipitates were probed with anti–h-warts/LATS1 antibody (G4) or with anti-zyxin antibody as in Fig. 1 F.
Figure 8. Disruption of endogenous zyxin localization on the mitotic apparatus by introducing h-warts/LATS1 protein fragments.
U2OS cells were microinjected with 1.0 mg/ml of GST–h-warts/LATS1 (amino acids 135–700) or GST alone, supplemented with
rhodamine-labeled tubulin. After preextraction and fixation, cells were incubated with rabbit anti-zyxin antibody and labeled with
FITC-conjugated anti–rabbit IgG antibody. Cells with rhodamine-labeled mitotic spindles (a, d, g, and j) were evaluated for zyxin stain-
ing (b, e, h, and k). Representative pictures injected with GST alone (a–f), or GST–h-warts (amino acids 135–700; g–l) in metaphase and
telophase are shown. The bottom panels (c, f, i, and l) show the phase-contrast images of the corresponding cells. Bars, 10 mm.Hirota et al. Mitosis-specific Interaction of h-warts and Zyxin 1085
and Drosophila, defects in profilin, which is shown to be
essential to form the actomyosin contractile ring, results in
the failure of cytokinesis (Balasubramanian et al., 1994;
Giansanti et al., 1998). Rho GTPase-mediated signal is re-
quired for the organization of cortical components to form
the contractile ring in mammalian cells (O’Connell et al.,
1999). Moreover, a number of genetic analyses converge
on the idea that components associated with mitotic spin-
dle may cooperate in formation of the contractile ring by
mediating the biochemical signaling or the physical inter-
action between two structures (Williams et al., 1995; Adams
et al., 1998). All these findings support the idea that zyxin
also plays a role in cell division by regulating actin fila-
ment assembly at midzone of the dividing cell.
The duration of mitosis in cells injected with h-warts/
LATS1(136–700) fragment, which significantly perturbed
zyxin specifying to the mitotic apparatus, was significantly
longer than that of control cells, mainly due to delay in exit
from mitosis (Fig. 9). An intriguing explanation for the ob-
servation is that the mislocalization of zyxin, as well as
zyxin-binding partners for actin polymerization, induces
discoordination of contractile ring in dividing cells, and
thereby delays their exit from mitosis. Alternatively,
h-warts/LATS1 enzymatic activity may be modulated by
zyxin, so that disruption of their interaction results in inac-
tivation of h-warts/LATS1 itself. It can not be excluded,
however, that another, as yet unknown, protein(s) is also
functionally impaired by h-warts/LATS1(136–700) frag-
ments to produce these results.
To maintain genomic stability and proper ploidy, it is
crucial that cell division occurs at the end of anaphase af-
ter chromosome segregation. The molecular mechanism
Figure 9. Effect of h-warts/LATS1(136–700) induction on mitosis
progression. (A) HeLa cells synchronized at the beginning of S
phase were coinjected with GST–h-warts/LATS1(136–700) or
GST and b-galactosidase. After release from S phase, cells were
fixed and analyzed for b-galactosidase activity. Chromatin is visu-
alized by staining cells with aceto-orcein, with which mitotic con-
densed chromatin can be easily identified by its strong staining.
Representative microscopic pictures of uninjected cells (a) from
10.5 h after release from S phase, GST-injected cells (b) and GST–
h-warts/LATS1(136–700) (c) from 12 h after the release. (B) Mi-
totic indices in cells injected with GST–h-warts/LATS1(136–700),
GST-mock, and b-galactosidase alone. Mitotic index was deter-
mined by counting the percentage of cells with condensed chroma-
tin and rounded-up morphology among b-galactosidase-positive
cells. Approximately 150 cells were injected and scored for each
experiment. Data are mean 6 SD of the six different experiments.The Journal of Cell Biology, Volume 149, 2000 1086
through which h-warts/LATS1 serves as a tumor sup-
pressor is unknown, but one possible explanation is that
h-warts/LATS1 may play a critical role in cell division pro-
cesses by forming a complex with zyxin on the mitotic
apparatus. Abrogation of this interaction may involve fail-
ure in normal mitotic progression, leading to chromosomal
instability, which is a hallmark of malignant tumors.
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